The Hidden Digestive Crisis: SIBO Misdiagnosis Endangers Millions
Millions of individuals suffering from a debilitating digestive disorder may have been incorrectly diagnosed with irritable bowel syndrome, exposing them to significant health risks including vitamin deficiencies, kidney complications, and even cancer. Medical professionals are raising alarms about this widespread issue, which stems from a condition known as small intestinal bacterial overgrowth.
Understanding SIBO and Its Rising Prevalence
SIBO occurs when bacteria in the small intestine multiply excessively, a problem that is increasingly common across the United Kingdom. The symptoms, such as diarrhoea and flatulence, are frequently confused with those of IBS, preventing patients from accessing effective treatments like tailored diet plans and antibiotics. In some distressing cases, patients have been told their symptoms are psychological and prescribed antidepressants, as highlighted in previous reports.
Experts are now advocating for greater awareness of this gastrointestinal issue and urging patients to seek second opinions if they suspect SIBO. Professor David Sanders explains the normal gut function: "The way the gut works is that when we eat food, our stomach acid destroys all the bacteria before it continues on to the small intestine." The remaining material then moves to the large intestine, home to the gut microbiome, which aids in vitamin production and nutrient breakdown.
Causes and Risk Factors of Bacterial Overgrowth
In contrast, the small intestine typically harbors minimal bacteria. However, in SIBO cases, bacteria escape into this area, leading to stomach pain and bloating. As food passes through, these bacteria ferment it, producing gas that causes discomfort. Several factors contribute to this, primarily linked to impaired digestion.
Reduced stomach acid, whether natural or due to medications like Proton Pump Inhibitors, increases SIBO risk. Professor Sanders notes, "We need acid to kill the bacteria that's on whatever we eat." With one in five Britons having used PPIs, prescriptions have tripled over two decades, potentially driving the SIBO trend.
Other causes include anatomical abnormalities, such as pouches in the intestine from surgery or conditions like diverticulosis, which allow bacteria to accumulate. Slowed gut transit, common after C-sections, in diabetes patients, the elderly, or weight-loss jab users, also elevates risk. Food poisoning may further contribute by decelerating digestion.
Symptoms and Diagnostic Challenges
Common symptoms encompass bloating, distended stomach, gas, excessive flatulence, diarrhoea, and unintentional weight loss, with diarrhoea and bloating being key diagnostic indicators. Diagnosis often involves ruling out severe conditions like bowel cancer, followed by stool tests or gastroscopy. Breath tests, though less invasive, are controversial due to reliability issues influenced by gut motility.
This diagnostic uncertainty leads to debates among gastroenterologists: some believe SIBO is underdiagnosed, while others argue over-diagnosis occurs due to test inaccuracies, explaining the rise in reported cases.
Treatment Options and Dietary Management
Once identified, primary treatment involves the antibiotic rifaximin, which can eliminate bacterial overgrowth but may harm healthy gut bacteria. Herbal antimicrobials like berberine and oregano offer alternatives, especially if initial treatments fail. Concurrently, patients often adopt a low FODMAP diet to reduce fibre intake and starve problematic bacteria.
- Foods to avoid include onion, garlic, alcohol, sugar alcohols, honey, beans, pulses, fizzy drinks, apples, wheat, and dairy.
The goal is to gradually reintroduce foods to identify triggers and restore a balanced diet. Probiotics may help rebalance gut microbes, though they are not a specific SIBO treatment. Addressing underlying causes, such as discontinuing PPIs or improving digestion speed, is crucial for long-term management.
Health Implications and Future Outlook
Untreated SIBO poses serious risks, with studies linking it to cancers like pancreatic, bile duct, and colon types. Experts emphasize the importance of accurate diagnosis and comprehensive treatment to mitigate these dangers and improve patient outcomes across the UK.
